Cardiac “hypertrophy” phenotyping: differentiating aetiologies with increased left ventricular wall thickness on echocardiography
2023 · Frontiers in Cardiovascular Medicine · 15 citations
https://doi.org/10.3389/fcvm.2023.1183485
P
Paul Geenty
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
41
Papers
102
Citations
6
h-index
3
i10-index
Paul Geenty is an academic researcher from The University of Sydney. The author has contributed to research in topics: Amyloidosis: Diagnosis, Treatment, Outcomes & Parathyroid Disorders and Treatments & Cardiovascular Function and Risk Factors. The author has an h-index of 6, co-authored 35 publications.
ORCID: 0000-0002-6737-6040Papers by this author
worksAtrial cardiomyopathy in cardiac amyloidosis: clinical imaging and manifestations
2025 · npj Cardiovascular Health · 6 citations
https://doi.org/10.1038/s44325-025-00043-z
Alterations in multi-layer strain in AL amyloidosis
2022 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.19208003
Transthyretin Cardiac Amyloidosis in Australia and New Zealand–A Multi-Site Snapshot for 2022
2024 · Heart Lung and Circulation · 0 citations
https://doi.org/10.1016/j.hlc.2024.05.014
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat